How Rapid Diagnostics Are Changing Overdose Response in the Synthetic Opioid Crisis
Faster, more accurate testing is helping clinicians identify synthetic opioids sooner and treat overdoses more effectively.
Faster, more accurate testing is helping clinicians identify synthetic opioids sooner and treat overdoses more effectively.
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
A novel biosensor detects SDMA in urine, providing a more accurate, non-invasive method for early kidney disease diagnosis and monitoring.
Luxor Scientific has developed advanced testing solutions to address the nation’s ongoing overdose crises.
Read MoreThe CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreA new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreQuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MoreNanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MoreThe new drug screening technique can rapidly detect the presence of 40 forensically relevant drugs from urine samples.
Read MoreTianeptine is often described as “gas-station dope” and products containing tianeptine commonly use the street names of “ZaZa” or “Tianna.”
Read MorePathogenDx’s UTI test is built on its D3 Array Platform. The multiplex test has a quick turnaround time with less waste.
Read MoreThe new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read MoreThis product design aims to transform workflows, expediting results for labs tasked to provide care for victims of drug-facilitated crimes.
Read MoreResearchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read MoreShenzhen Superbio Technology received FDA clearance for a point-of-care instrument intended for the detection of fentanyl in human urine.
Read MoreKeystone Lab has officially added xylazine to its in-house urine clinical toxicology menu.
Read More